photo #9023234

🚨 Newly Released Epstein Documents Reveal Financier’s Ties to Key Figures in Transgender Medicine InfrastructureDocuments unsealed under the Epstein Files Transparency Act, enacted in late 2025 and leading to phased public releases through early 2026, include previously private emails that connect Jeffrey Epstein to individuals who played central roles in building transgender surgical programs and related research at major American medical institutions.Independent researcher Sayer Ji has examined six specific pieces of correspondence—now part of the public record under identifiers such as EFTA02667053 and EFTA00835004—detailing Epstein’s financial contributions, directed research prompts, and efforts to position transgender topics within elite academic, medical, and financial circles. Most of these interactions took place after Epstein’s 2008 conviction and 2009 plea agreement.In one 2016 exchange, plastic surgeon Dr. Jess Ting informed Epstein that he had received a $50,000 research grant from the Jeffrey Epstein VI Foundation for a breast cancer–related paper. Ting went on to describe his newly appointed role as surgical director of Mount Sinai Health System’s Center for Transgender Medicine and Surgery as “the most gratifying, worthwhile, and fascinating thing I’ve ever done.” He later sought Epstein’s support for the documentary Born to Be, which followed the center’s work, and Epstein shared related updates with others in his network.Separate correspondence with evolutionary biologist Robert Trivers, a longtime recipient of Epstein funding, shows Epstein pressing him in February 2016 to write on “transgender in the bio world,” telling Trivers, “you are unique .. i want to see you piece on transgender in the bio world. this is for you. not me.” By March 2019, after funding had lapsed, Trivers cited financial hardship and agreed to refocus his work on “transsexuality” or “transgender biology” in exchange for renewed support. Epstein conditioned further assistance on that shift and rejected other proposed topics as less valuable.Additional messages reveal Epstein treating the subject strategically. In August 2017 he advised former MIT Media Lab director Joi Ito on pitching science initiatives to Bill Gates, recommending a move away from “transgender” toward brain-stimulation technologies as a more fundable area. In October 2017 he remarked to former Obama White House Counsel Kathy Ruemmler that “transgender [is] not yet on wall street,” adding a smiley face, apparently noting the topic’s gradual penetration into elite financial networks. Elsewhere he casually suggested “transgender?” as a leading term-paper topic for an associate.Taken together, the correspondence suggests Epstein did more than maintain peripheral associations: he provided direct funding, commissioned specific academic output, and helped shape the narrative environment around what would become a rapidly expanding sector of American medicine, particularly as gender-affirming surgical programs grew at leading academic medical centers.These disclosures surface against the backdrop of recent policy changes, including the Department of Health and Human Services’ 2025 restrictions on certain gender-affirming interventions for minors. They raise enduring questions about institutional awareness of Epstein-linked funding, the integrity of research streams, the process of informed consent in pediatric care, and the foundations of public confidence in medical institutions.🔗 The complete analysis, including embedded document references and further context on the individuals involved, is available in Sayer’s article here: https://sayerji.substack.com/p/six-documents-that-connect-jeffrey